TECHNOLOGY
All-ScaleFlow™
The world’s first All-Scale-in-One mRNA manufacturing solution.
Dillico’s game-changing All-ScaleFlow™ technology offers an entirely new approach that enables the end-to-end production of mRNA-LNP, from In-Vitro Transcription to LNP encapsulation.

Production of mRNA-LNP at any scale. Using the same equipment and process design space.
Unique advantages of our mRNA-LNP manufacturing technology
Our continuous All-ScaleFlow™ technology enables the production of GMP-grade mRNA-LNP, with volumes per batch ranging from 1,000 doses for pre-clinical / phase 1 to 10 million doses (few mg to kg) for commercial production in a matter of days, all using the same equipment and process design space.
All-ScaleFlow™ technology holds a number of advantages over existing approaches, making it both unique and competitive.
Batch skid train |
Batch integrated solution |
Continuous micro-fluidic solution |
Dillico All-ScaleFlow® Technology |
|
---|---|---|---|---|
Confined flow |
||||
Small scale down to 1,000 doses |
||||
Large scale up to 10m doses |
||||
Direct Scale-Up |
||||
Customizable process |
||||
Digital Twin |
Difficult |
Difficult |
Possible |